Understanding the origins of Malformations of the Cortical development
Ossola and Kalebic. Frontiers in Neuroscience 2022
The cerebral cortex – the outer brain layer – accounts approximately for half of the human and mammalian brain mass and controls language, memory, reasoning, and consciousness. Specialised cortex cells – the neural progenitors – are responsible for the specification, positioning and maturation of neurons in the cortex, which are essential for brain development. Alteration of any of these events leads to structural abnormalities of the cerebral cortex, called Malformations of Cortical Development (MCDs). By impairing brain development, MCDs result in abnormal brain size and thickness, which represent the basis of several neurodevelopmental disorders.
Nereo Kalebic and Chiara Ossola at the HT Neurogenomics Research Centre review how two key features of the neuronal progenitor cells, i.e. their ability to proliferate and polarise, impact on brain development, if misregulated. Furthermore, they discuss the role of cell signaling pathways and metabolism in the onset of MCDs and how using appropriate in vivo and in vitro models can help advancing personalized medicine. In summary, the authors provide a comprehensive overview of how the cell biology of the neuronal progenitors is involved in MDC onset.
The review is published in Frontiers in Neuroscience.
Share:
You could also like:
-
How sortilin senses thyroglobulin along its pathway to thyroid hormone release
Human Technopole researchers have identified the molecular mechanisms by which the membrane receptor sortilin binds thyroglobulin along its pathway to the release of thyroid hormones within the thyroid gland. The results of the research were published in Nature Communications and highlight that sortilin senses thyroglobulin via a short flexible “tag” which appears to be a common motif for the recognition of other partner proteins throughout our body.
-
AI4Life: A European Success for Artificial Intelligence in the Life Sciences
The AI4Life project, co-led by Florian Jug (Computational Biology Research Centre at Human Technopole) and Anna Kreshuk (EMBL), received the highest possible score in the European Commission’s final review, recognising its scientific impact and the quality of its achievements in applying artificial intelligence to biological image analysis.
-
Human Technopole awarded FIS grant for precision immunotherapy research
The Giustacchini Group of the Genomics Research Centre of Human Technopole has been awarded a €1.66 million grant from the Fondo Italiano per la Scienza (FIS 2) to advance precision immunotherapy for haematological malignancies. The three-year project, titled “Tailoring Precision Immunotherapy to Haematological Malignancies”, aims to develop more effective cell-based therapies for blood cancers by integrating molecular, cellular and systems-level analyses.
-
Highlights from the 2nd Conference “Future Trends in Translational Medicine”
Turning scientific discoveries into real-world therapies was the focus of the second international conference “Future Trends in Translational Medicine – From Molecules to Therapies,” held at the Complesso Universitario di San Giovanni a Teduccio in Naples on 30 -31 October 2025.
-
Happy Holidays and a Bright New Year from Human Technopole
As 2025 comes to a close, we look back at a year shaped by connection, discovery and growth. At Human Technopole, progress happens when perspectives meet, between disciplines, technologies and people. Our holiday card captures this idea visually: what looks like a festive forest is actually a colon under the microscope, a structure that changes depending on how you look at it, reminding us that science often begins with a shift in perspective.